Hodgkin's lymphoma, mixed cellularity
MONDO:0004633A subtype of classical Hodgkin lymphoma with scattered Reed-Sternberg and Hodgkin cells in a diffuse or vaguely nodular mixed inflammatory background without nodular sclerosing fibrosis. (WHO, 2008)
Also known as: Hodgkin lymphoma, mixed cellularity, Hodgkin's disease mixed cellularity, Hodgkin's disease, mixed cellularity of unspecified site, Hodgkin's lymphoma mixed cellularity, MCCHL, MCHL, Mixed cellularity Classic Hodgkin lymphoma, classic Hodgkin lymphoma, mixed cellularity type
1894 clinical trials for this condition and its sub-types, 4 tagged with Hodgkin's lymphoma, mixed cellularity itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New combo therapy shows promise for older hodgkin lymphoma patients
Disease control CompletedThis phase II trial tested a combination of the targeted drug brentuximab vedotin with standard chemotherapy (AVD) in 49 older adults with untreated Hodgkin lymphoma. The goal was to see how many patients achieved complete remission. The approach aims to improve outcomes by targe…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo shows promise for tough lymphomas
Disease control CompletedThis study tested adding lenalidomide to a standard chemotherapy regimen (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the best dose and see if the combination improves how long patients live without their cancer getting wors…
Phase 1/2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC